BRIEF-Arrowhead Pharmaceuticals Q2 EPS USD 2.75 Vs. IBES Estimate USD -0.2

Reuters
13 May
BRIEF-Arrowhead Pharmaceuticals Q2 EPS USD 2.75 Vs. IBES Estimate USD -0.2

May 12 (Reuters) - Arrowhead Pharmaceuticals Q2 operating income USD 381.202 million vs. IBES estimate USD -38.9 million.

  • Q2 revenue USD 542.709 million vs. IBES estimate USD 29.9 million
  • Q2 net income USD -2.582 million vs. IBES estimate USD -29.7 million
  • Q2 operating expenses USD 161.507 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10